VSee Health, Inc. Cash and Restricted Cash
VSee Health, Inc. (VSEE) had Cash and Restricted Cash of $454.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $454.15K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.35M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.05M; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $5.27M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $472.76K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $454.15K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.35M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.05M 10-Q · filed 2026-08-14 | $5.27M 10-K · filed 2026-03-31 |
| 2025-09-30 | $472.76K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $291.60K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $410.12K 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $326.12K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $2.33M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.11M 10-Q/A · filed 2025-11-20 | |
| 2024-03-31 | $689.28K 10-Q · filed 2025-10-15 | $724.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $118.73K 10-K · filed 2026-03-31 | $1.86K 10-K · filed 2024-04-12 |
| 2023-09-30 | $159.54K 10-Q · filed 2024-11-14 | $507.00 10-Q · filed 2023-11-20 |
| 2023-06-30 | $73.33K 10-Q · filed 2024-09-23 | $30.86K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $16.33K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $230.66K 10-K/A · filed 2025-08-29 | $107.00K 10-K · filed 2023-04-12 |
| 2022-09-30 | $44.97K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $191.13K 10-Q · filed 2023-08-21 | |
| 2022-03-31 | $509.72K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $760.01K 10-K · filed 2024-04-12 | |
| 2021-09-30 | $5.50K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $77.11K 10-Q · filed 2022-08-15 | |
| 2021-03-29 | $0.00 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |